Targeting Stress Neuroadaptations for Addiction Treatment: A Commentary on Kaye et al. (2017).

372 KAYE ET AL. (2017—this issue) identify the importance of targeting stress for addiction treatment and how unpredictable stress plays a pivotal role in addiction etiology. They present an elegant model examining startle potentiation during unpredictable (vs. predictable) stressors in cued threat tasks to further elucidate the role of brain stress system neuroadaptations in addiction. Of note, modeling stress reactivity in addiction and, more broadly, examining neurobiological targets for stress-induced drug-motivated behaviors lend support to the seamless translation between preclinical and human research. Ultimately, the feasibility of both forward and back translation based on this program of research will likely lead to the development of novel treatments that are better able to target specific stress neurocircuitry to attenuate drug craving and self-administration and increase options to providers for the treatment of stress-precipitated substance use. The review by Kaye et al. (2017) should be particularly encouraging to the scientific community seeking to expand on the startle potentiation model and to examine or develop other models of addiction that tap into stress pathophysiology. Kaye and colleagues focus on the corticotrophinreleasing factor (CRF) and norepinephrine (NE) systems and the central extended amygdala (CeA). Indeed, there is an increasing amount of support for the role of the CRF and NE systems in addiction and stress-precipitated substance use (Back et al., 2010; Fox et al., 2012, 2014; McKee et al., 2015), particularly in rodent models of stress-induced reinstatement of drug seeking (Lê et al., 2011; Mantsch et al., 2016; Zislis et al., 2007). Unfortunately, there has been little translation of these findings to humans, and too few human laboratory studies have examined CRF or noradrenergic mechanisms underlying substance use. The pathophysiology of stress and neuroadaptations within brain stress systems is complex and expands beyond the CRF and NE systems and the CeA. Further investigation of other stress systems and stress-related neurocircuitry is also relevant and important in the etiology and treatment of addiction. Research remains limited on the role of urocortin, dynorphin, neuropeptide Y, hypocretins/orexin, and brain regions such as the striatum and prefrontal cortex (PFC) in COMMENTARY

[1]  J. J. Curtin,et al.  Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence. , 2017, Journal of studies on alcohol and drugs.

[2]  G. Koob,et al.  A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence , 2017, Neuropsychopharmacology.

[3]  Y. Mineur,et al.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence. , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[4]  A. Arnsten,et al.  A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation , 2015, Journal of psychopharmacology.

[5]  Jenna M. Sullivan,et al.  Sex Differences in the Brain's Dopamine Signature of Cigarette Smoking , 2014, The Journal of Neuroscience.

[6]  Dan J Stein,et al.  Associations between childhood adversity, adult stressful life events, and past-year drug use disorders in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). , 2014, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[7]  R. Sinha,et al.  Sex Differences in Guanfacine Effects on Drug Craving and Stress Arousal in Cocaine-Dependent Individuals , 2014, Neuropsychopharmacology.

[8]  R. Wightman,et al.  Advances in studying phasic dopamine signaling in brain reward mechanisms. , 2013, Frontiers in bioscience.

[9]  Hao Huang,et al.  White Matter Disruptions in Adolescents Exposed to Childhood Maltreatment and Vulnerability to Psychopathology , 2012, Neuropsychopharmacology.

[10]  R. Sinha,et al.  Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. , 2012, Alcoholism, clinical and experimental research.

[11]  H. Becker,et al.  Chronic social isolation and chronic variable stress during early development induce later elevated ethanol intake in adult C57BL/6J mice. , 2011, Alcohol.

[12]  R. Sinha,et al.  Stress decreases the ability to resist smoking and potentiates smoking intensity and reward , 2011, Journal of psychopharmacology.

[13]  Y. Shaham,et al.  Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats , 2011, Psychopharmacology.

[14]  A. Arnsten The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder , 2010, Expert review of neurotherapeutics.

[15]  S. Gilman,et al.  Childhood adversity, adult stressful life events, and risk of past-year psychiatric disorder: a test of the stress sensitization hypothesis in a population-based sample of adults , 2009, Psychological Medicine.

[16]  A. Arnsten Stress signalling pathways that impair prefrontal cortex structure and function , 2009, Nature Reviews Neuroscience.

[17]  A. Bruijnzeel,et al.  Effects of the CRF receptor antagonist d-Phe CRF(12–41) and the α2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats , 2007, Neuropharmacology.

[18]  Y. Shaham,et al.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress , 2016, Neuropsychopharmacology.

[19]  K. Brady,et al.  Reactivity to laboratory stress provocation predicts relapse to cocaine. , 2010, Drug and alcohol dependence.